National Bank of Canada’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22
Closed -$46 3050
2025
Q3
$46 Hold
22
﹤0.01% 2791
2025
Q2
$54 Hold
22
﹤0.01% 2899
2025
Q1
$28 Hold
22
﹤0.01% 2765
2024
Q4
$71 Hold
22
﹤0.01% 2817
2024
Q3
$69 Buy
+22
New +$72 ﹤0.01% 2581

National Bank of Canada's MURA Position: Q4 2025 in Review

National Bank of Canada sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 22 shares — an estimated $46 sold.

National Bank of Canada first reported a position in MURA in Q3 2024 and held it in 5 quarters. The position peaked at $71 in Q4 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • National Bank of Canada reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • National Bank of Canada sold 22 Mural Oncology shares in Q4 2025, an estimated $46.
  • National Bank of Canada first reported a position in Mural Oncology in Q3 2024 and held it in 5 quarters.
  • National Bank of Canada's Mural Oncology position peaked at $71 in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.